Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Cady

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Headache|July 24, 2018
Qualitative Change in Migraine Prevention?Roger Cady, Richard B Lipton
Postgraduate Medicine|October 26, 2007
An update on migraine pathophysiology and mechanism-based pharmacotherapeutics for migraineRoger Cady, David M Biondi
Headache|May 16, 2002
Mixing sumatriptanRichard B Lipton, Roger Cady
Headache|November 16, 2011
Insights into the mechanism of onabotulinumtoxinA in chronic migrainePaul L Durham, Roger Cady
Headache|January 7, 2012
Pharmacological synergy: the next frontier on therapeutic advancement for migraineAndrew Blumenfeld, Chris Gennings, Roger Cady
Headache|February 26, 2004
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapyPaul L Durham, Ryan Cady, Roger Cady
Headache|September 1, 2006
Repression of stimulated calcitonin gene-related peptide secretion by topiramatePaul L Durham, Christine Niemann, Roger Cady
Headache|March 21, 2002
Primary headaches: a convergence hypothesisRoger Cady, Curtis Schreiber, Kathleen Farmer, et al.
Current Medical Research and Opinion|September 24, 2004
Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severeRoger Cady, Arthur Elkind, Jerome Goldstein, et al.
Headache|November 17, 2007
Does early migraine treatment shorten time to headache peak and reduce its severity?X Henry Hu, Daisy Ng-Mak, Roger Cady
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Headache|July 24, 2018
Qualitative Change in Migraine Prevention?Roger Cady, Richard B Lipton
Postgraduate Medicine|October 26, 2007
An update on migraine pathophysiology and mechanism-based pharmacotherapeutics for migraineRoger Cady, David M Biondi
Headache|May 16, 2002
Mixing sumatriptanRichard B Lipton, Roger Cady
Headache|November 16, 2011
Insights into the mechanism of onabotulinumtoxinA in chronic migrainePaul L Durham, Roger Cady
Headache|January 7, 2012
Pharmacological synergy: the next frontier on therapeutic advancement for migraineAndrew Blumenfeld, Chris Gennings, Roger Cady
Headache|February 26, 2004
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapyPaul L Durham, Ryan Cady, Roger Cady
Headache|September 1, 2006
Repression of stimulated calcitonin gene-related peptide secretion by topiramatePaul L Durham, Christine Niemann, Roger Cady
Headache|March 21, 2002
Primary headaches: a convergence hypothesisRoger Cady, Curtis Schreiber, Kathleen Farmer, et al.
Current Medical Research and Opinion|September 24, 2004
Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severeRoger Cady, Arthur Elkind, Jerome Goldstein, et al.
Headache|November 17, 2007
Does early migraine treatment shorten time to headache peak and reduce its severity?X Henry Hu, Daisy Ng-Mak, Roger Cady
Pageof 10